Cancer diagnosis in Brazil in the COVID-19 era.

Cancer diagnosis in Brazil in the COVID-19 era.
复制标题

DOI:
10.1053/j.seminoncol.2020.12.002
复制
发表时间:
2021-04
影响因子:
4
通讯作者:
Martelli-Júnior H
Martelli-Júnior H
中科院分区:
医学3区
文献类型:
--
作者:
Marques NP;Silveira DMM;Marques NCT;Martelli DRB;Oliveira EA;Martelli-Júnior H

文献摘要

参考文献

被引文献

相似文献

在巴西,癌症患者的综合护理和治疗由国家癌症预防和控制政策管理,由巴西统一医疗保健系统(SUS)在经认证的医疗机构提供。由于COVID-19大流行,州联邦政府已实施多项限制措施,而癌症诊断参考中心亦受该等措施影响。因此,本研究旨在比较巴西流感大流行之前和期间迄今为止的SUS导向癌症诊断。自大流行期开始以来,巴西所有地区的癌症诊断平均数大幅下降。所有地区的新发癌症病例数量都大幅下降,从北部的-24.3%到东北部地区的-42.7%不等。巴西整体平均赤字达到35.5%,相当于每月约15,000例未确诊的癌症病例。在大流行期间,巴西新诊断的癌症病例大幅减少,因为公共卫生服务的咨询受到限制性措施的影响。因此,必须紧急采取有效措施,以尽量减少COVID-19大流行对癌症患者护理造成的损害及由此产生的负面健康影响。
The comprehensive care and treatment for cancer patients in Brazil, regulated by the National Cancer Prevention and Control Policy, is provided by Brazilian Unified Healthcare System (SUS) in certified health institution. Due the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments, and cancer diagnosis reference centers were also impacted by these measures. Thus, this study aimed to compare SUS-oriented cancer diagnosis in Brazil before and during the pandemic so far. The average number of cancer diagnoses has dropped considerably in all Brazilian Regions since the pandemic period started. The number of new cancer cases has plunged in all regions, ranged from −24.3% in the North to −42.7% in Northeast region. The overall Brazilian average deficit reached 35.5%, corresponding to about 15,000 undiagnosed cases of cancer monthly. The pandemic period has dramatically reduced the diagnosis of new cases of cancer in Brazil, since consultations in public health services were compromised by restrictive measures. Therefore, effective measures must be urgently put in action in order to minimize the damage, and consequently, the negative health impacts caused by the COVID-19 pandemic in the care of cancer patients.
DOI: 10.6004/jnccn.2020.7639
发表时间: 2021-12-01
影响因子: 13.4
作者:
Kircher, Sheetal M.;Mulcahy, Mary;Benson, Al B., III
通讯作者: Benson, Al B., III
DOI: 10.3332/ecancer.2020.1060
发表时间: 2020-06-17
影响因子: 1.8
作者:
Estevez-Diz, Maria del Pilar;Bonadio, Renata Colombo;Carvalho, Jesus Paula
通讯作者: Carvalho, Jesus Paula
DOI: 10.1093/ajcp/aqaa177
发表时间: 2021-01-01
影响因子: 3.5
作者:
Ferrara, Gerardo;De Vincentiis, Ludovica;Saragoni, Luca
通讯作者: Saragoni, Luca
DOI: 10.1634/theoncologist.2020-0213
发表时间: 2020-04-27
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Al-Shamsi, Humaid O.;Alhazzani, Waleed;Xie, Conghua
通讯作者: Xie, Conghua
DOI: 10.1016/s0140-6736(20)30627-9
发表时间: 2020-04-11
期刊: LANCET
影响因子: 168.9
作者:
Remuzzi, Andrea;Remuzzi, Giuseppe
通讯作者: Remuzzi, Giuseppe